Higgy N A, Salicioni A M, Russo I H, Zhang P L, Russo J
Breast Cancer Research Laboratory, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
Mol Carcinog. 1997 Dec;20(4):332-9. doi: 10.1002/(sici)1098-2744(199712)20:4<332::aid-mc2>3.0.co;2-l.
Subtractive hybridization was used to isolate genes expressed uniquely in the immortalized human breast epithelial cell (HBEC) line MCF-10F and not in the mortal HBEC line S-130, from which MCF-10F cells were derived. We identified a 233-bp cDNA that was expressed in MCF-10F cells and not in their mortal counterpart S-130 cells. Sequence comparison with the GenBank database revealed that the cDNA was identical to the gene encoding human ferritin heavy H chain. Northern blot analysis using the isolated cDNA as a probe showed a differentially expressed 1.1-kb transcript of ferritin H in total RNA from the immortal MCF-10F cells, MCF-10F cells treated with the chemical carcinogens 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene, and the breast cancer cell lines MCF-7, HBL-100, T-47D, and BT-20. No ferritin H transcript was detected in the mortal line S-130 or in other primary HBEC cultures. Increased levels of mRNA transcript signals were also detected in total RNA from breast cancer tissue samples. Tissue with ductal hyperplasia had higher expression levels than normal adjacent mammary tissue. In situ hybridization showed high levels of ferritin H transcript in mammary tissue areas with ductal hyperplasia, carcinoma in situ, and infiltrating ductal carcinoma. This is the first report of the differential expression and upregulation of human ferritin H chain gene in immortal HBECs. It may be an important factor in the process of immortalization, possibly an early stage of malignant transformation of HBECs, providing cells with iron necessary for growth and clonal expansion. Also, ferritin iron, once released, may increase the level of reactive iron, leading to an increase in oxygen free-radical generation, oxidative DNA damage, and mutation.
采用消减杂交技术从永生的人乳腺上皮细胞(HBEC)系MCF-10F中分离出特异表达的基因,该细胞系起源于 mortal HBEC系S-130,而这些基因在S-130细胞中不表达。我们鉴定出一个233bp的cDNA,它在MCF-10F细胞中表达,而在其对应的 mortal细胞S-130中不表达。与GenBank数据库进行序列比对发现,该cDNA与人铁蛋白重链H基因编码区完全一致。以分离得到的cDNA为探针进行Northern杂交分析,结果显示在永生的MCF-10F细胞、经化学致癌物7,12-二甲基苯并[a]蒽和苯并[a]芘处理的MCF-10F细胞以及乳腺癌细胞系MCF-7、HBL-100、T-47D和BT-20的总RNA中,铁蛋白H存在差异表达的1.1kb转录本。在mortal细胞系S-130或其他原代HBEC培养物中未检测到铁蛋白H转录本。在乳腺癌组织样本的总RNA中也检测到mRNA转录本信号水平升高。伴有导管增生的组织比相邻正常乳腺组织具有更高的表达水平。原位杂交显示,在伴有导管增生、原位癌和浸润性导管癌的乳腺组织区域中铁蛋白H转录本水平较高。这是首次报道人铁蛋白H链基因在永生HBECs中的差异表达及上调。它可能是细胞永生化过程中的一个重要因素,可能是HBECs恶性转化的早期阶段,为细胞生长和克隆扩增提供必要的铁。此外,一旦释放,铁蛋白铁可能会增加活性铁水平,导致氧自由基生成增加、氧化性DNA损伤和突变。